SHARIF ALHAMED: Open Payments
NPI 1275683500 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 15 payments from 7 companies in 2025. Trend: 2023 $162 · 2024 $158 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $129 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Organon LLC | 2 | $43 |
| Novo Nordisk Inc | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Cranial Technologies, Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: REPATHA, GVOKE HYPOPEN, OTEZLA, NEXPLANON, PREVNAR 20, Doc Band, BEXSERO.
Industry payments across IL — which companies pay providers there.
